Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Tables)

v3.19.1
Shareholders' Equity (Tables)
3 Months Ended
Mar. 31, 2019
Equity [Abstract]  
Schedule of warrants

A summary of the Company’s warrants to purchase common stock activity is as follows:

 

    Shares Underlying
Warrants
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Life (years)
    Aggregate
Intrinsic
Value
 
Outstanding and exercisable at December 31, 2018     2,629,468     $ 5.24       3.58     $  
Granted     115,000       6.28                  
Outstanding and exercisable at March 31, 2019     2,744,468     $ 5.28       3.30     $  
Schedule of stock option activity

A summary of the Company’s stock option activity is as follows:

 

    Shares Underlying
Options
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Life (years)
    Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2018     2,520,101     $ 4.32       8.72     $  
Granted     837,144       4.32                  
Exercised     (416 )     3.78               *  
Forfeited/cancelled     (35,834 )     4.28                  
Outstanding at March 31, 2019     3,320,995     $ 4.32       8.56     $  

*represents amount less than $1,000

Schedule of option pricing model using weighted average assumptions

The options granted during the three months ended March 31, 2019 and 2018 were valued using the Black-Scholes option pricing model using the following weighted average assumptions:

 

    For the three months ended March 31,  
    2019     2018  
Expected term, in years     5.8       5.7  
Expected volatility     70.57 %     67.04 %
Risk-free interest rate     2.56 %     2.63 %
Dividend yield            
Grant date fair value   $ 2.73     $ 2.79  
Schedule of restricted stock unit awards activity

A summary of the Company’s restricted stock unit awards activity is as follows:

 

      Number of
Shares
    Weighted
Average Grant
Date Fair Value
 
Nonvested at December 31, 2018       165,000     $ 810  
Granted       76,112       329  
Vested       (10,313 )     51  
Nonvested at March 31, 2019       230,799     $ 1,088  
Schedule of stock-based compensation

The following table sets forth total non-cash stock-based compensation for the issuance of common stock, options to purchase common stock, warrants to purchase common stock, and restricted stock unit award by operating statement classification for the three months ended March 31, 2019 and 2018:

 

    Three Months ended March 31,  
    2019     2018  
Research and development   $ 125     $ 68  
Sales and marketing     63       29  
General and administrative     753       505  
Total(1)(2)   $ 941     $ 602  
  (1) As of March 31, 2019 and December 31, 2018, the Company recorded a prepaid expense in the amount of $240 and $344, respectively, for the value of vested warrants for future services to be rendered.
  (2) As of March 31, 2019 and December 31, 2018, the Company recorded a warrant liability in the amount of $25 and $22, respectively, for the value of warrants to be issued for services provided.